Accredo Health Group Inc
- View government funding actions
- Memphis, TN 381348822
- Phone: 770-423-1737
- Corporate URL: www.accredohealthgroup.com/
- Estimated Number of Employees: 3,000
- Estimated Annual Receipts: $50,000,000,000
- Business Start Date: 1996
- Contact Person: Linda Oneal
- Contact Phone: 407-833-4519
- Contact Email: linda.oneal@curascript.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Industries Served: Pharmacies and Drug Stores, Home Health Care Services
- Product Areas: SERVICES (ENGINEERING), R&D- DEFENSE OTHER: SERVICES (ENGINEERING DEVELOPMENT)
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $9,653 - Monday the 19th of December 2011
Veterans Affairs Department
438-SIOUX FALLS VA MEDICAL CENTER
VETERAN MEDICINE - $8,400 - Friday the 30th of December 2011
Veterans Affairs Department
246-NETWORK CONTRACTING OFFICE 6
EMERGENCY: JAKAFI 5MG TABLETS - $8,056 - Wednesday the 28th of December 2011
Federal Prison System
DEVENS, FMC
TYVASO REFILL FOR INMATE PRESCRIPTIONS - $8,056 - Monday the 21st of November 2011
Federal Prison System
DEVENS, FMC
TYVASO REFILL KIT FOR FMC DEVENS - $8,056 - Friday the 17th of February 2012
Federal Prison System
DEVENS, FMC
TYVASO REFILL KIT FOR FMC DEVENS - $7,840 - Friday the 17th of October 2014
Indian Health Service
DEPT OF HHS/INDIAN HEALTH SERVICE
ANASCORP (CENTRUROIDES (SCORPION) IMMUNE F (AB')2(EQUINE) INJECTION - $7,840 - Thursday the 24th of May 2012
Indian Health Service
DEPT OF HHS/INDIAN HEALTH SERVICE
SCORPION ANTIVENOM FOR SCORPION BITES - $7,310 - Tuesday the 6th of March 2012
Federal Prison System
ALLENWOOD, FCC
PERSCRIPTION MEDICINE - $7,310 - Tuesday the 26th of June 2012
Federal Prison System
ROCHESTER, FMC
EMERGENCY PURCHASE TRACLEER 125MG - $7,310 - Friday the 11th of May 2012
Federal Prison System
SPRINGFIELD, USMCFP
1 BOTTLE OF TRACLEER 125 MG (60 TABLETS/BOTTLE)
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.